Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.70 |
| ▸ | PTH1R | Q03431 | 10/20 | 0.66 |
| ▸ | NPY1R | P25929 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 1/20 | 0.64 |
| ▸ | NPY4R | P50391 | 1/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.64 |
| ▸ | GLP1R | P43220 | 4/20 | 0.63 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182766 | 0.93 | PTH1R (0.73) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL31182694 | 0.93 | CXCR4 (0.71) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL31183001 | 0.93 | NPY1R (0.67) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL30432427 | 0.92 | KEAP1 (0.64) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL31182954 | 0.91 | KEAP1 (0.67) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL31182586 | 0.91 | GLP1R (0.70) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30006939 | 0.91 | KEAP1 (0.70) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL30404538 | 0.91 | KEAP1 (0.65) | KEAP1PTH1RNPY1RNPY2RNPY4R | |
| SCHEMBL30218939 | 0.90 | CXCR4 (0.65) | CXCR4CXCL8 | |
| SCHEMBL30932069 | 0.90 | GLP1R (0.74) | KEAP1NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE50618-E1 | Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same | PHARMAIN CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |